TGTing Guo

Ting Guo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ting Guo has a total of 145 co-authors. Here are the top co-authors by number of shared publications:

  • Yingying Qin

    State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, China

    17 shared publications
  • Keyan Xu

    State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, Shandong 250012, China

    7 shared publications
  • Yingying Qin

    State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan 250012, China

    7 shared publications
  • Bingying Xu

    6 shared publications
  • Hanni Ke

    Center for Reproductive Medicine, Shandong University , Jinan, China

    6 shared publications
  • Shidou Zhao

    State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan 250012, China; Key Laboratory of Reproductive Endocrinology (Shandong University), Ministry of Education, Jinan 250012, China

    6 shared publications

Latest Publications

  • Open Access

    Age-specific anti-Müllerian hormone reference values using an ultrasensitive assay: Associations with ovarian aging and menopausal transition symptoms

    by Keyan Xu, Yehuan Yang, Peihao Liu, Shuxin Ma, Chunmei Zhang, Xin Liang, Xiaowei Wu, Xinyi Wu, Zifeng Cao, Yilin Yang, et al.

    Background: Accurately assessing ovarian aging remains a critical challenge in women’s health, particularly during the late reproductive stage and menopausal transition. Anti-Müllerian hormone (AMH) is widely used to reflect ovarian reserve, but its application in midlife women is limited by the lack of standardized age-specific reference values and poor sensitivity of conventional assays at low AMH levels. This study aimed to establish age-specific AMH reference percentiles in midlife Chinese women using an ultrasensitive assay and to evaluate their clinical relevance for assessing ovarian aging during the menopausal transition. Methods: We analyzed serum AMH levels in 10,543 Chinese women aged 34–56 years from a nationally representative cohort using a highly sensitive assay (limit of detection: 0.003 ng/mL). Generalized additive models for location, scale, and shape were used to construct age-specific AMH percentiles. Associations with longitudinal AMH decline ( n = 2521), perimenopausal symptoms (PMSs) (via modified Kupperman index), and menopausal status ( n = 422 postmenopausal women) were evaluated. Results: The ultrasensitive assay enabled detection of AMH levels in most women aged 44–49 years and distinguished postmenopausal from premenopausal women (median 0.043 vs . 0.187 ng/mL, P < 0.001). Area under the curve for menopause diagnosis was 0.72 (cutoff = 0.0055 ng/mL). Age-specific AMH percentiles were established based on a nationwide cross-sectional cohort of 10,543 women, providing the first standardized reference for late reproductive stages. In the longitudinal cohort, women with baseline AMH below the 10th percentile experienced faster decline before age 40. Among women aged 35–55 years, lower AMH percentiles were associated with more severe PMSs (β = 0.12), particularly vasomotor symptoms (VMSs). Conclusions: Ultrasensitive AMH profiling enables the construction of age-specific reference percentiles applicable to women in late reproductive stages. This framework enhances the clinical utility of AMH for individualized fertility counseling, PMS management, and menopausal status assessment.

  • Open Access

    Social isolation and loneliness associate with early menopause and mortality in women: a UK Biobank cohort study

    by Yuteng Wang, Yu Qi, Zifeng Cao, Keyan Xu, Ruoliu Xia, Shigang Zhao, Linlin Cui, Daimin Wei, Han Zhao, Shuyan Tang, et al.

    Reproductive aging is an emerging public health priority amid demographic shifts. Early menopause (EM), indicative of accelerated reproductive aging, is associated with an elevated risk of premature mortality. While social isolation (SI) and loneliness (LO) are established psychosocial determinants of health, their associations with EM and their combined effects with menopausal status on mortality risk remain unquantified. This study investigated the associations of SI and LO with EM and all-cause mortality. This study included 79,578 Caucasian women from the UK Biobank cohort, of whom 6,778 experienced EM (menopause at age 40-45) and 72,800 experienced normal menopause (NM, age 46-55). SI (score: 0, 1, ≥2) was derived from three indicators: living arrangement, frequency of social contact, and participation in social activities; LO (score 0-2) was assessed based on self-reported loneliness and frequency of confiding in someone close. Multivariable-adjusted models were used to evaluate the odds of EM. All-cause mortality risk was assessed using Cox proportional hazards models, stratified by menopause status. Higher levels of SI and LO were independently associated with an increased prevalence of EM (e.g. SI ≥ 2: OR = 1.09, 95% CI 1.00-1.20; LO = 2: OR = 1.13, 95% CI 1.02-1.25). Critically, the detrimental impact of social adversity on survival was significantly greater in women with EM compared to those with NM. After full adjustment, women with EM and SI index ≥ 2 had a 55% increased mortality risk (HR = 1.55, 95% CI 1.21-1.99), whereas the risk increase for women with NM was 17% (HR = 1.17, 95% CI 1.07-1.28). A similar pattern was observed for LO (e.g. LO = 2, EM: HR = 1.42, 95% CI 1.07-1.88 vs. NM: HR = 1.14, 95% CI 1.02-1.27). Moreover, Kaplan-Meier curves showed a progressively wider survival gap between EM and NM as SI/LO levels increased. Lower SI and LO were associated with lower EM-related excess mortality. SI and LO were associated with EM and premature mortality. Women with EM are especially vulnerable to the negative effects of social adversity. Integrating psychological and social support into menopause care is essential, and reducing SI and LO may promote healthier aging. NA.


  • Open Access

    Genetic variants in the homologous recombination pathway as common risk for premature ovarian insufficiency and ovarian cancer

    by Yiran Li, Zifeng Cao, Jie Gao, Peiwen Xu, Yuan Gao, Lei He, Wenkai Ji, Yingying Qin, Ye Hong, Ting Guo, et al.

  • Open Access

    Menopause status and modifiable risk factors for early menopause in China: a nationwide cross-sectional study on geographical disparities

    by Ting Guo, Xinyi Wu, Peihao Liu, Zifeng Cao, Keyan Xu, Li Yang, Guangmei Huang, Qianqian Ma, Xiaomin Yang, Xin Gao, et al.

  • MEI4 variations drive female reproductive disorders via impaired oocyte abundance and developmental potential

    by Yiyang Wang, Yu Qi, Keyan Xu, Shuyan Tang, Luyi Tan, Bingying Xu, Ying Wang, Shuxian Zhang, Yang Zou, Yuan Gao, et al.


  • Open Access

    Stress granule clearance mediated by V-ATPase-interacting protein NCOA7 mitigates ovarian aging

    by Ting Dong, Nianyu Li, Huirui Wang, Hanbing Zhu, Yinghui Gao, Yue Liu, Fang Fang, Xiaojie Fu, Pinxin Si, Cheng Li, et al.

    Reproductive longevity is essential for female fertility and healthy aging; however, the role of stress response, especially stress granule accumulation, in ovarian aging remains elusive and interventions are lacking. Here, we identified deleterious mutations and decreased expression of NCOA7, a stress-response protein related to granulosa cell senescence in women with physiological and pathological ovarian aging. NCOA7 deletion accelerates oxidative stress-related cellular senescence, ovarian aging and fecundity decline in mice. Mechanistically, NCOA7 partitions into the stress granule containing G3BP1–V-ATPase and facilitates autophagic degradation of stress granules to relieve stress. Boosting granulophagy with rapamycin or lipid nanoparticle-based mRNA delivery of NCOA7 accelerates stress granule clearance, alleviating cellular senescence in human granulosa cells and delaying ovarian aging in mice. This study depicts a mechanism for ovarian resilience to stress and provides potential targets for therapeutic strategies to alleviate ovarian aging.


  • Open Access

    Biallelic BRCA2 variants induce premature ovarian insufficiency by impaired meiotic homologous recombination

    by Xinyi Wu, Qian Zhang, Chang Li, Shuning Zhuang, Hongyuan Liu, Xue Jiao, Shidou Zhao, Yingying Qin, Ting Guo

    The DNA damage response plays a pivotal role in ovarian aging. Breast cancer susceptibility gene 2 (BRCA2), which participates in homologous recombination (HR), is a key regulator of natural menopause. Rare BRCA2 variants have been identified in patients with premature ovarian insufficiency (POI). However, the underlying molecular mechanisms are not well understood. Using a viable mouse model, Brca2c.68-1G>C/c.4384-4394del, carrying compound heterozygous variants mirroring the ones identified in a POI pedigree, we illustrated the essential role of BRCA2 in primordial follicle pool establishment. Germline deficiency of BRCA2 did not affect primordial germ cell (PGC) proliferation but impaired the recruitment of RAD51 and DMC1 to programmed DNA double-strand breaks (DSBs) during meiotic HR, causing postnatal oocyte depletion. Moreover, Brca2c.68-1G>C/c.4384-4394del mice presented increased tumor susceptibility. These findings confirmed the pathogenicity of BRCA2 biallelic variants in POI, revealing the dual impact on germ cell development and somatic cancer risk, underscoring the necessity of tumor surveillance in POI patients with BRCA2 mutations.


  • Open Access

    Bi-allelic variation ofFANCJ(BRIP1) identified in premature ovarian insufficiency

    by Xinmiao He, Mengchun Hu, Hongyuan Liu, Chunmei Zhang, Xin Liang, Xiaowei Wu, Manting Yang, Anmiao Sun, Runxin Yao, Shidou Zhao, et al.

    Objective: Premature ovarian insufficiency (POI) is defined as the depletion of ovarian function before 40 years of age, affecting approximately 3.7% of women in their reproductive age worldwide. Previous studies revealed several genes involved in the Fanconi anaemia (FA) pathway participate in the pathogenesis of POI, such asFANCAandFANCM. FA pathway maintains rapid proliferation in the developing primordial germ cells by deregulating transcription-replication conflicts, which is crucial for the establishment of sufficient ovarian reserve.FANCJencodes a DNA helicase located downstream of the FA pathway promoting DNA damage repair and cell proliferation. Recently, two heterozygousFANCJmissense variants have been reported in patients with POI, suggesting haploinsufficiency of FANCJ participates in the pathogenesis of the disease. In this study, to further explore the contribution ofFANCJvariants in POI, we reported a rare homozygousFANCJstart-loss variation in one patient with POI and illustrated its pathogenicity by in vitro functional studies.Methods: The loss-of-function (LoF) variants ofFANCJwere screened in our internal whole-exome sequencing (WES) database of POI. Sanger sequencing and WES analysis were employed on the proband and the patient’s family members to illustrate the origin of the bi-allelic variant. Cycloheximide chase assay was performed to demonstrate the impact of the variant on the protein stability of FANCJ. Protein ubiquitination assay was performed to confirm the accelerated degradation pathway of FANCJ protein.Results: Through the variation screening, a bi-allelic variant ofFANCJ(NM_032043.3:c.1A>G, p.Met1Val) was identified in one case. The functional study showed that the start-loss variant affected FANCJ protein stability by accelerated protein degradation through the ubiquitin-proteasome pathway.Conclusion: Our findings provide further genetic evidence of theFANCJvariant participating in the pathogenesis of POI, expand the inherited mode and highlight the essential role of the FA pathway in maintaining ovarian function.

  • Associations of long-term exposure to fine particulate matter and its components with ovarian aging: Evidence from a cross-sectional study in China

    by Zifeng Cao, Xinyi Wu, Hongyuan Liu, Keyan Xu, Yehuan Yang, Manting Yang, Daimin Wei, Shidou Zhao, Xue Jiao, Qi Zhao, et al.